Perrigo - Best Pharma Stocks of 2007
Company: Perrigo
Starting stock price: $17.61
Ending stock price: $35.01
Percent Change: 98.81%
Details: Perrigo develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. In December 2007 Perrigo won FDA approval for an OTC, generic heartburn treatment the company will market in partnership with Dexcel Pharma.
More News:
Perrigo gets OK for generic heartburn drug. Report
Dexcel gets right to sell copycat Prilosec. Report
More stories about Perrigo
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: